Jonah S. Ufferfilge

FDA investigator

Appears on 17 documents from 2019 to 2023, most often at sites in Connecticut. Most often cites design and construction features (21 CFR 211.42).

17
Documents on file
7.1
Observations per 483
2019
First seen
2023
Most recent

What they cite most

From 119 observations

Activity by year

2019: 5, 2020: 1, 2021: 2, 2022: 5, 2023: 4

Where

Connecticut 7 · India 2 · Massachusetts 2 · Maryland 1 · New Hampshire 1 · Rhode Island 1

Is Jonah S. Ufferfilge coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

17 documents, newest first
FirmOpen
483 SCA Pharmaceuticals, LLCOct 20, 2023 · Windsor, Connecticut
483 Washington Homeopathic ProductsAug 23, 2023 · Berkeley Springs, West Virginia
483 Afton Scientific, LLCApr 6, 2023 · Charlottesville, Virginia
483 Ecometics, IncFeb 6, 2023 · Norwalk, Connecticut
483 Pharmaceutics International, Inc.Nov 14, 2022 · Cockeysville, Maryland
483 Cipla LimitedAug 26, 2022 · Verna, Salcette, Goa, India
483 Sun Pharmaceutical Industries LimitedAug 12, 2022 · Mohali, India

About this profile

What does Jonah S. Ufferfilge inspect?

Jonah S. Ufferfilge appears on 17 documents on file covering 16 sites, most often in Connecticut.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.67 and 21 CFR 211.68.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jonah S. Ufferfilge is dated Oct 20, 2023.